22In chronic lymphocytic leukemia (CLL), stabilizing mutations of NOTCH1, affecting up to 10–15% of cases, have been associated to poor prognosis, disease progression and refractoriness to chemotherapy. NOTCH1 mutations are significantly overrepresented in trisomy 12 CLL, a disease subset frequently expressing CD49d, the α4 chain of the very-late-activation-4 integrin, a well-known key regulator of microenviromental interactions, and negative prognosticator in CLL. In the present study, by analysing a wide cohort of 1180 CLL, we observed a very strong association between the presence of NOTCH1 mutations and the expression of CD49d (Po0.0001), occurring also outside the trisomy 12 CLL subset. Using both the MEC-1 CLL-like cells stably trans...
The purpose of this study was to compare the expression and function of NOTCH1 in chronic lymphocyti...
Background NOTCH1 PEST domain mutations in chronic lymphocytic leukemia have recently been shown to ...
Despite recent therapeutic improvements, Chronic Lymphocytic Leukemia (CLL) remains an incurable dis...
In chronic lymphocytic leukemia (CLL), stabilizing mutations of NOTCH1, affecting up to 10-15% of ca...
In chronic lymphocytic leukemia (CLL), stabilizing mutations of NOTCH1, affecting up to 10-15% of ca...
CD49d, the alpha-chain of the integrin heterodimer α4β1, was identified among the strongest predicto...
Activating mutations of NOTCH1 (a well-known oncogene in T-cell acute lymphoblastic leukemia) are pr...
CD49d, the alpha-chain of the integrin heterodimer \u3b14\u3b21, was identified among the strongest ...
The Notch signaling pathway plays a fundamental role for the terminal differentiation of multiple ce...
Chronic lymphocytic leukemia (CLL) is a B cell malignancy and represents the most common leukemia in...
<p>Chronic lymphocytic leukemia (CLL) is an incurable B-cell neoplasm characterized by highly variab...
Chronic lymphocytic leukemia (CLL) is a heterogeneous disease with highly variable clinical courses ...
In chronic lymphocytic leukemia (CLL), NOTCH1 mutations have been associated with clinical resistanc...
In chronic lymphocytic leukemia (CLL), NOTCH1 mutations have been associated with clinical resistanc...
The purpose of this study was to compare the expression and function of NOTCH1 in chronic lymphocyti...
The purpose of this study was to compare the expression and function of NOTCH1 in chronic lymphocyti...
Background NOTCH1 PEST domain mutations in chronic lymphocytic leukemia have recently been shown to ...
Despite recent therapeutic improvements, Chronic Lymphocytic Leukemia (CLL) remains an incurable dis...
In chronic lymphocytic leukemia (CLL), stabilizing mutations of NOTCH1, affecting up to 10-15% of ca...
In chronic lymphocytic leukemia (CLL), stabilizing mutations of NOTCH1, affecting up to 10-15% of ca...
CD49d, the alpha-chain of the integrin heterodimer α4β1, was identified among the strongest predicto...
Activating mutations of NOTCH1 (a well-known oncogene in T-cell acute lymphoblastic leukemia) are pr...
CD49d, the alpha-chain of the integrin heterodimer \u3b14\u3b21, was identified among the strongest ...
The Notch signaling pathway plays a fundamental role for the terminal differentiation of multiple ce...
Chronic lymphocytic leukemia (CLL) is a B cell malignancy and represents the most common leukemia in...
<p>Chronic lymphocytic leukemia (CLL) is an incurable B-cell neoplasm characterized by highly variab...
Chronic lymphocytic leukemia (CLL) is a heterogeneous disease with highly variable clinical courses ...
In chronic lymphocytic leukemia (CLL), NOTCH1 mutations have been associated with clinical resistanc...
In chronic lymphocytic leukemia (CLL), NOTCH1 mutations have been associated with clinical resistanc...
The purpose of this study was to compare the expression and function of NOTCH1 in chronic lymphocyti...
The purpose of this study was to compare the expression and function of NOTCH1 in chronic lymphocyti...
Background NOTCH1 PEST domain mutations in chronic lymphocytic leukemia have recently been shown to ...
Despite recent therapeutic improvements, Chronic Lymphocytic Leukemia (CLL) remains an incurable dis...